Overexpression of BiP partially suppresses apoptosis of human gastric cancer cells induced by celecoxib, a non-steroidal anti-inflammatory drug (NSAID), and the knockdown of BiP dramatically enhances apoptosis [113]. Here, HSPA5 is linked to gastric cancer.